Alzecure Pharma Ab Stock Cash Flow From Operations
| AC6 Stock | EUR 0.44 0.12 37.50% |
Fundamental analysis of ALZECURE PHARMA allows traders to better anticipate movements in ALZECURE PHARMA's stock price by examining its financial health and performance throughout various phases of its business cycle.
ALZECURE |
ALZECURE PHARMA AB Company Cash Flow From Operations Analysis
ALZECURE PHARMA's Operating Cash Flow reveals the quality of a company's reported earnings and is calculated by deducting company's income taxes from earnings before interest, taxes, and depreciation (EBITDA). In other words, Operating Cash Flow refers to the amount of cash a firm generates from the sales or products or from rendering services. Operating Cash Flow typically excludes costs associated with long-term investments or investment in marketable securities and is usually used by investors or analysts to check on the quality of a company's earnings.
Current ALZECURE PHARMA Cash Flow From Operations | 356.17 K |
Most of ALZECURE PHARMA's fundamental indicators, such as Cash Flow From Operations, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, ALZECURE PHARMA AB is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Operating Cash Flow shows the difference between reported income and actual cash flows of the company. If a firm does not have enough cash or cash equivalents to cover its current liabilities, then both investors and management should be concerned about the company having enough liquid resources to meet current and long term debt obligations.
| Competition |
In accordance with the recently published financial statements, ALZECURE PHARMA AB has 356.17 K in Cash Flow From Operations. This is 99.93% lower than that of the Healthcare sector and 99.9% lower than that of the Drug Manufacturers - Specialty & Generic industry. The cash flow from operations for all Germany stocks is 99.96% higher than that of the company.
ALZECURE Cash Flow From Operations Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses ALZECURE PHARMA's direct or indirect competition against its Cash Flow From Operations to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of ALZECURE PHARMA could also be used in its relative valuation, which is a method of valuing ALZECURE PHARMA by comparing valuation metrics of similar companies.ALZECURE PHARMA is currently under evaluation in cash flow from operations category among its peers.
ALZECURE Fundamentals
| Return On Equity | -1.55 | |||
| Return On Asset | -0.78 | |||
| Shares Outstanding | 59.19 M | |||
| Shares Owned By Insiders | 34.06 % | |||
| Shares Owned By Institutions | 5.56 % | |||
| Price To Earning | (183.73) X | |||
| EBITDA | 2.58 M | |||
| Net Income | (7.21 M) | |||
| Cash And Equivalents | 18.67 M | |||
| Cash Per Share | 0.06 X | |||
| Total Debt | 723.85 K | |||
| Debt To Equity | 0.80 % | |||
| Current Ratio | 48.72 X | |||
| Book Value Per Share | 0.28 X | |||
| Cash Flow From Operations | 356.17 K | |||
| Number Of Employees | 14 | |||
| Beta | 0.74 | |||
| Market Capitalization | 24.47 M | |||
| Z Score | 19.8 |
About ALZECURE PHARMA Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze ALZECURE PHARMA AB's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of ALZECURE PHARMA using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of ALZECURE PHARMA AB based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in ALZECURE Stock
ALZECURE PHARMA financial ratios help investors to determine whether ALZECURE Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in ALZECURE with respect to the benefits of owning ALZECURE PHARMA security.